Market Tracker

06/23 5:16pm ET

Geron Corp (NASDAQ:GERN)

2.94
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
1.81
Today|||52-Week Range
3.15
+42.03%
Year-to-Date

Today’s Trading

Previous close2.94
Today’s open2.97
Day’s range2.88 - 2.99
Volume1,737,403
Average volume (3 months)1,765,035
Market cap$468.0M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...+0.12+1.04%
ADAPAdaptimmune Therapeu...+0.03+0.61%
SYRSSyros Pharmaceutical...+0.57+3.38%
BCRXBioCryst Pharmaceuti...+0.03+0.49%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts